<SEC-DOCUMENT>0001213900-21-010620-index.html : 20210219
<SEC-HEADER>0001213900-21-010620.hdr.sgml : 20210219
<ACCEPTANCE-DATETIME>20210219170642
ACCESSION NUMBER:		0001213900-21-010620
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210216
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210219
DATE AS OF CHANGE:		20210219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38174
		FILM NUMBER:		21656990

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea135915-8k_citiuspharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea135915-8k_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea135915ex4-1_citiuspharma.htm
<DESCRIPTION>FORM OF INVESTOR WARRANT ISSUED FEBRUARY 19, 2021
<TEXT>
Document 2 - file: ea135915ex4-1_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea135915ex4-2_citiuspharma.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT ISSUED FEBRUARY 19, 2021
<TEXT>
Document 3 - file: ea135915ex4-2_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea135915ex5-1_citiuspharma.htm
<DESCRIPTION>OPINION OF WYRICK ROBBINS YATES & PONTON, LLP
<TEXT>
Document 4 - file: ea135915ex5-1_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea135915ex10-1_citiuspharma.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED FEBRUARY 16, 2021, BY AND BETWEEN CITIUS PHARMACEUTICALS, INC. AND THE PURCHASERS SIGNATORY THERETO
<TEXT>
Document 5 - file: ea135915ex10-1_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea135915ex99-1_citiuspharma.htm
<DESCRIPTION>PRESS RELEASE OF FEBRUARY 17, 2021
<TEXT>
Document 6 - file: ea135915ex99-1_citiuspharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ea135915ex99-2_citiuspharma.htm
<DESCRIPTION>PRESS RELEASE OF FEBRUARY 19, 2021
<TEXT>
Document 7 - file: ea135915ex99-2_citiuspharma.htm

</DOCUMENT>
</SEC-DOCUMENT>